Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Xiao Xiao Dinglin"'
Autor:
Xin-Ru Chen, Xue Hou, Xiao-Xiao Dinglin, Yong-Dong Liu, Yin Li, Wei Zheng, De-Lan Li, Jing Chen, Xiao-Liang Wu, Kai-Cheng Wang, Shu-Xiang Ma, Yin-Duo Zeng, Li-Kun Chen
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundThis study aimed to comprehensively analyze the characteristics, treatment patterns, and survival outcomes of non-small-cell lung cancer (NSCLC) patients initially diagnosed with brain metastases (BMs) in real-world practice.MethodsWe enrol
Externí odkaz:
https://doaj.org/article/590703adb1334ba3a86b2833ac069d4a
Autor:
Jian-Li Zhao, Xiao-Xiao Dinglin, Ya-Ping Yang, Si-Min Luo, Yang-Yang Cai, Jie Chai, Dong-Geng Liu, Ying Wang, He-Rui Yao
Publikováno v:
Journal of Clinical Oncology. 40:e13015-e13015
e13015 Background: Eribulin is a non-taxane microtubule inhibitor, which was approved for the third-line treatment of advanced breast cancer (ABC) in China in 2019. However, the efficacy and safety data of eribulin for the ABC in Chinese patients is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::020c0cae6218f567aa35f5b2cd5224be
https://doi.org/10.1200/jco.2022.40.16_suppl.e13015
https://doi.org/10.1200/jco.2022.40.16_suppl.e13015
Autor:
Qing Liu, De lan Li, Shu Xiang Ma, Yin Duo Zeng, Xiao Xiao Dinglin, Xin ru Chen, Jian Zhong Liang, Li Kun Chen, Fang Wang
Publikováno v:
Clinical Lung Cancer. 18:e179-e186
Background The current published prognosis models for brain metastases (BMs) from cancer have not addressed the issue of either newly diagnosed non–small-cell lung cancer (NSCLC) with BMs or the lung cancer genotype. We sought to build an adjusted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd533d6a5eba2799aa03a83f657f395
https://doi.org/10.1016/j.cllc.2016.12.016
https://doi.org/10.1016/j.cllc.2016.12.016
Autor:
Zhao Wang, Tao Qin, Shu Xiang Ma, Li Kun Chen, Xiao Xiao Dinglin, Yin Duo Zeng, Xue Hou, Ji Jie Huang
Publikováno v:
Chinese Journal of Cancer
Toxic epidermal necrolysis (TEN) is a rare acute life-threatening mucocutaneous disorder that is mostly drug-related (80%-95%). It is clinically characterized as a widespread sloughing of the skin and mucosa. AP regimen (pemetrexed plus cisplatin) ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e5ed225c1684e604601bed0ed2b960f
https://doi.org/10.5732/cjc.014.10151
https://doi.org/10.5732/cjc.014.10151
Autor:
Xing, Yang, Qian, Hu, Lan-Xin, Hu, Xiao-Rong, Lin, Jie-Qiong, Liu, Xiao, Lin, Xiao-Xiao, Dinglin, Jia-Yi, Zeng, Hai, Hu, Man-Li, Luo, He-Rui, Yao
Publikováno v:
Discovery medicine. 24(131)
Chemotherapy is a cornerstone treatment for early and advanced stage breast cancer patients. However, resistance to chemotherapy remains a major obstacle, resulting in disease relapse and progression. Emerging studies demonstrated that miRNAs regulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e704a5b57376bbabb39b53d66b475356
https://pubmed.ncbi.nlm.nih.gov/28972876
https://pubmed.ncbi.nlm.nih.gov/28972876
Autor:
Guo Zhen Liu, Wei Dong Wei, He Huang, Yin Duo Zeng, Xiao Xiao Dinglin, Guang Chuan Xu, Li Kun Chen, Hai Liao
Publikováno v:
Medical Oncology. 29:1687-1692
To study the treatment outcomes of brain-only metastases from small-cell lung cancer (SCLC) at initial diagnose treated by chemotherapy with concurrent brain and thoracic radiotherapy (RT). From Jan 2004 to Jan 2009, 36 treatment-naïve SCLC patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f10b88f433470d34d55293c853474d
https://doi.org/10.1007/s12032-011-0040-8
https://doi.org/10.1007/s12032-011-0040-8
Publikováno v:
Asia-Pacific journal of clinical oncology. 11(3)
This systematic review and meta-analysis was performed to assess the efficacy and side effects between single-agent and doublet chemotherapy in first-line treatment of advanced non-small cell lung cancer with performance status 2 (PS2).We searched fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3779dca80e4d4e6cac258049b9e87190
https://pubmed.ncbi.nlm.nih.gov/25866140
https://pubmed.ncbi.nlm.nih.gov/25866140
Autor:
Fei Xu, Shu Xiang Ma, Hai Liao, Jian Zhong Liang, Xiao Xiao Dinglin, Li Kun Chen, Tao Qin, Yin Duo Zeng, Li Zhang, Wei Dong Wei
Publikováno v:
Oncotarget
// Yin-duo Zeng 1, * , Hai Liao 2, * , Tao Qin 1, * , Li Zhang 1 , Wei-dong Wei 3 , Jian-zhong Liang 4 , Fei Xu 1 , Xiao-xiao Dinglin 5 , Shu-xiang Ma 1 , Li-kun Chen 1 1 Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2415232e5a21e3e1d3b657d09b9c47d
https://pubmed.ncbi.nlm.nih.gov/25788260
https://pubmed.ncbi.nlm.nih.gov/25788260
Publikováno v:
Journal of neuro-oncology. 112(3)
Pemetrexed-based chemotherapy presented about 40 % response rate (RR) on brain lesions of non-small cell lung cancer (NSCLC). But whole brain radiotherapy (WBRT) is still the standard treatment when surgery or radio-surgery is not feasible. This tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6070a262c66409d6b8159209fbd5fd
https://pubmed.ncbi.nlm.nih.gov/23420398
https://pubmed.ncbi.nlm.nih.gov/23420398
Autor:
Fei Xu, Li Kun Chen, Yin Duo Zeng, Li Zhang, Xiao Xiao Dinglin, Ying Liang, Jun Ling Liu, Hai Liao
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 13(3)
Background: Gefitinib, a tyrosine kinase inhibitor (TKI) of epidermal growth factor receptor (EGFR), is used both as a single drug and concurrently with whole brain radiotherapy (WBRT) the standard treatment for brain metastases (BM), and is reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198445a787a1550bdf75ae292bdbcd49
https://pubmed.ncbi.nlm.nih.gov/22631670
https://pubmed.ncbi.nlm.nih.gov/22631670